Table 1.

IL-9, IL-21 and IL-23 plasma levels in healthy controls and ESRD patients with and without CMV seropositivity

Parameters	Controls (n = 27)	ESRD (n = 117)	p
IL-9 (pg/ml)	799 ± 2203	435 ± 930	0.74
IL-21 (pg/ml)	368 ± 751	194 ± 213	0.61
IL-23 (pg/ml)	2.9 ± 11	10 ± 17	<0.001
	Controls (n = 27)	CMV-IgG- (n = 49)
IL-9 (pg/ml)	799 ± 2203	336 ± 810	0.53
IL-21 (pg/ml)	368 ± 751	156 ± 175	0.25
IL-23 (pg/ml)	2.9 ± 11	5.4 ± 7.8	0.002
	Controls (n = 27)	CMV-IgG+ (n = 68)
IL-9 (pg/ml)	799 ± 2203	506 ± 1007	0.31
IL-21 (pg/ml)	368 ± 751	221 ± 235	0.96
IL-23 (pg/ml)	2.9 ± 11	14 ± 20	<0.0001
	CMV-IgG- (n = 49)	CMV-IgG+ (n = 68)
IL-9 (pg/ml)	336 ± 810	506 ± 1007	0.02
IL-21 (pg/ml)	156 ± 175	221 ± 235	0.12
IL-23 (pg/ml)	5.4 ± 7.8	14 ± 20	<0.001

Mann-Whitney-U test was used to calculate p values

Data are given as mean ± SD